Modulation of protein tyrosine phosphorylation during G1/S transition in activated human T-lymphoblasts.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 8253732)

Published in J Biol Chem on December 15, 1993

Authors

Y Churcher1, S E Moss

Author Affiliations

1: Department of Physiology, University College of London, United Kingdom.

Articles by these authors

(truncated to the top 100)

The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1984) 9.28

The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol (1984) 7.68

The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology (1984) 5.91

Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA (1988) 4.31

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology (1998) 4.21

Visual impairment in diabetes. Ophthalmology (1984) 3.64

The Wisconsin Epidemiologic Study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol (1994) 3.24

The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc (2000) 3.17

Endocytic vesicles move at the tips of actin tails in cultured mast cells. Nat Cell Biol (1999) 3.17

An alternative method of grading diabetic retinopathy. Ophthalmology (1986) 3.05

The relationship of age-related maculopathy, cataract, and glaucoma to visual acuity. Invest Ophthalmol Vis Sci (1995) 2.99

The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology (1992) 2.70

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology (1995) 2.70

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol (1989) 2.59

The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology (1989) 2.51

Refractive status in the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci (1994) 2.36

Alcohol intake and the risk of coronary heart disease mortality in persons with older-onset diabetes mellitus. JAMA (1999) 2.35

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology (1991) 2.34

The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol (1989) 2.31

Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology (1985) 2.26

Diversity in the lipocortin/calpactin family. Cell (1988) 2.11

Epidemiology of proliferative diabetic retinopathy. Diabetes Care (1992) 1.91

Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol (1994) 1.91

The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med (2000) 1.86

Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med (1994) 1.78

How many steps of progression of diabetic retinopathy are meaningful? The Wisconsin epidemiologic study of diabetic retinopathy. Arch Ophthalmol (2001) 1.65

Annexin 2 has an essential role in actin-based macropinocytic rocketing. Curr Biol (2001) 1.60

Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol (1999) 1.59

Annexins and membrane dynamics. Biochim Biophys Acta (1997) 1.56

Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol (1984) 1.56

The NEI-VFQ-25 in people with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Ophthalmol (2001) 1.55

Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology (1985) 1.55

Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med (1989) 1.54

Parental history of diabetes in a population-based study. Diabetes Care (1996) 1.54

Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care (1990) 1.54

Age-related eye disease and survival. The Beaver Dam Eye Study. Arch Ophthalmol (1995) 1.53

The relation of systemic hypertension to changes in the retinal vasculature: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc (1997) 1.53

The epidemiology of epiretinal membranes. Trans Am Ophthalmol Soc (1994) 1.51

Relation of smoking to the incidence of age-related maculopathy. The Beaver Dam Eye Study. Am J Epidemiol (1998) 1.47

Quantitation of optic disc cupping. Ophthalmology (1985) 1.45

Incident cataract surgery: the Beaver Dam eye study. Ophthalmology (1997) 1.44

Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med (1996) 1.42

Practical guidelines for the assessment and treatment of selective mutism. J Am Acad Child Adolesc Psychiatry (1995) 1.41

Primary structure of the human, membrane-associated Ca2+-binding protein p68 a novel member of a protein family. EMBO J (1988) 1.38

Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study. Surgery (1979) 1.38

Is obesity related to microvascular and macrovascular complications in diabetes? The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med (1997) 1.35

The Wisconsin epidemiological study of diabetic retinopathy: a review. Diabetes Metab Rev (1989) 1.33

Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol (1995) 1.30

The 10-year incidence of renal insufficiency in people with type 1 diabetes. Diabetes Care (1999) 1.27

Self-rated health and diabetes of long duration. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care (1998) 1.25

Older-onset diabetes and lens opacities. The Beaver Dam Eye Study. Ophthalmic Epidemiol (1995) 1.24

The relation of socioeconomic factors to age-related cataract, maculopathy, and impaired vision. The Beaver Dam Eye Study. Ophthalmology (1994) 1.23

Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med (1989) 1.20

Optic disc cupping as clinically estimated from photographs. Ophthalmology (1987) 1.20

Retinal microaneurysm counts and 10-year progression of diabetic retinopathy. Arch Ophthalmol (1995) 1.16

A cohort study of the relationship of diabetic retinopathy to blood pressure. Arch Ophthalmol (1995) 1.16

Inter-observer variation in refraction and visual acuity measurement using a standardized protocol. Ophthalmology (1983) 1.15

Correlation of lysosomal enzyme abnormalities in various forms of adult leukaemia. J Clin Pathol (1983) 1.14

Imaging multiple phases of neurodegeneration: a novel approach to assessing cell death in vivo. Cell Death Dis (2010) 1.13

The influence of combined kidney-pancreas transplantation on the progression of diabetic retinopathy. A case series. Ophthalmology (1994) 1.12

Endocytosis occurs independently of annexin VI in human A431 cells. J Cell Biol (1994) 1.12

The relationship of retinal microaneurysm counts to the 4-year progression of diabetic retinopathy. Arch Ophthalmol (1989) 1.11

The association of microalbuminuria with diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology (1993) 1.10

Structural evolution of the annexin supergene family. Trends Genet (1994) 1.10

The incidence of gross proteinuria in people with insulin-dependent diabetes mellitus. Arch Intern Med (1991) 1.09

Genetic marker associations with proliferative retinopathy in persons diagnosed with diabetes before 30 yr of age. Diabetes (1992) 1.08

Weight gain associated with improved glycemic control in population-based sample of subjects with type I diabetes. Diabetes Care (1990) 1.07

Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression. Cancer Res (1996) 1.07

Does the severity of diabetic retinopathy predict pregnancy outcome? J Diabet Complications (1989) 1.06

Detection of drusen and early signs of age-related maculopathy using a nonmydriatic camera and a standard fundus camera. Ophthalmology (1992) 1.06

Immunological development and cardiovascular function are normal in annexin VI null mutant mice. Mol Cell Biol (1999) 1.05

Is there an ethnic difference in the effect of risk factors for diabetic retinopathy? Ann Epidemiol (1993) 1.05

Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degeneration. Eye (Lond) (2011) 1.04

Diabetes, hyperglycemia, and age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology (1992) 1.03

The incidence of hypertension in insulin-dependent diabetes. Arch Intern Med (1996) 1.03

Intraocular pressure in diabetic persons. Ophthalmology (1984) 1.03

Retinal emboli and stroke: the Beaver Dam Eye Study. Arch Ophthalmol (1999) 1.02

Self-rated health and mortality in people with diabetes. Am J Public Health (1994) 1.00

Annexins in the secretory pathway. Cell Mol Life Sci (1997) 1.00

Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care (1993) 0.99

Annexinopathies. Subcell Biochem (2007) 0.99

Prevalence of self-reported erectile dysfunction in people with long-term IDDM. Diabetes Care (1996) 0.99

Expression of annexin VI (p68, 67 kDa-calelectrin) in normal human tissues: evidence for developmental regulation in B- and T-lymphocytes. Histochemistry (1991) 0.99

Blood pressure and hypertension in diabetes. Am J Epidemiol (1985) 0.98

Is age-related maculopathy associated with cataracts? Arch Ophthalmol (1994) 0.98

Annexin VI has tumour-suppressor activity in human A431 squamous epithelial carcinoma cells. Br J Cancer (1995) 0.97

Lens thickness and five-year cumulative incidence of cataracts: The Beaver Dam Eye Study. Ophthalmic Epidemiol (2000) 0.97

Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy? Ophthalmology (1993) 0.97

The Wisconsin epidemiologic study of diabetic retinopathy: an update. Aust N Z J Ophthalmol (1990) 0.97

Blood pressure, hypertension and retinopathy in a population. Trans Am Ophthalmol Soc (1993) 0.97

Expression of annexin VI in A431 carcinoma cells suppresses proliferation: a possible role for annexin VI in cell growth regulation. Biochim Biophys Acta (1994) 0.96

Membrane segregation and downregulation of raft markers during sarcolemmal differentiation in skeletal muscle cells. Dev Biol (2003) 0.96

Imaging apoptosis in the eye. Eye (Lond) (2011) 0.96

Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care (1996) 0.94

Retinopathy in young-onset diabetic patients. Diabetes Care (1985) 0.94

Structure of the human annexin VI gene. Proc Natl Acad Sci U S A (1994) 0.93

Does insulin-like growth factor I predict incidence and progression of diabetic retinopathy? Diabetes (1995) 0.91

Is serum cholesterol associated with progression of diabetic retinopathy or macular edema in persons with younger-onset diabetes of long duration? Am J Ophthalmol (1999) 0.91

The medical management of hyperglycemia over a 10-year period in people with diabetes. Diabetes Care (1996) 0.91

The relation of socioeconomic factors to the incidence of proliferative diabetic retinopathy and loss of vision. Ophthalmology (1994) 0.91